News Breaks |
|
|
| September 28, 2012 |
| 14:42 EDT |  | SNY | Sanofi initiates voluntary recall of Typhim Vi vaccine, FDA says
Sanofi is initiating a voluntary recall of some lots of its Typhim Vi vaccine, according to an FDA release. The FDA says, "There is no safety concern related to this action," and stated that Sanofi is taking this action because the selected vaccine lots are at risk for lower antigen content. Reference Link |
|
|
News For SNY From The Last 14 Days Check below for free stories on SNY the last two weeks. |
|
|
| May 23, 2013 |
| 08:18 EDT | | SNY | Merrimack completes enrollement in a Phase 2 study of MM-121 with Sanofi
 Subscribe for More Information |
|
| May 21, 2013 |
| 07:44 EDT |  | SNY | Sachs Associates to host a forum
Subscribe for More Information |
|
| May 20, 2013 |
| 17:26 EDT | | SNY | Regeneron, Genentech, Sanofi enter into 'Zaltrap agreement'
Subscribe for More Information |
|
| 11:27 EDT | | SNY | Appeals court reverses, remands patent ruling in Sanofi suit against Mylan, Teva
Subscribe for More Information |
|
| May 17, 2013 |
| 08:03 EDT | | SNY | Sanofi reports positive topline results from pivotal Phase III Jakarta study
Subscribe for More Information |
|
| 05:18 EDT | | SNY | Sanofi says JAK2 inhibitor for myelofibrosis met primary endpoint
Subscribe for More Information |
|
| May 15, 2013 |
| 15:16 EDT | | SNY | Sanofi systemic sclerosis treatment designated for orphan drug status
Subscribe for More Information |
|
| 05:39 EDT | | SNY | Sanofi, Regeneron announce patient enrollment in two Phase 3 trials
Subscribe for More Information |
|
| May 13, 2013 |
| 09:44 EDT |  | SNY | Several companies reportedly interested in buying Adcock Ingram, Globes says
Subscribe for More Information |
|
| 07:30 EDT | | SNY | TechConnect to host a summit
2013 National Innovation Summit is being held in Washington, D.C. on May 12-16. |
| |
|
|
|
|
